PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors

IUBMB Life

Volumn 64, Issue 4, 2012, Pages 324-330

  Abourbeh, Galith ^a   Shir, Alexei ^b   Mishani, Eyal ^a   Ogris, Manfred ^c   Rödl, Wolfgang ^c   Wagner, Ernst ^c   Levitzki, Alexander ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

EGFR; GE11; polyIC

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; MACROGOL; PEPTIDE; POLYETHYLENEIMINE; POLYINOSINIC POLYCYTIDYLIC ACID; TYROSYLHISTIDYLTRYPTOPHYLTYROSYLGLYCYLTYROSYLTHREONYLPROLYLGLUTAMINYLASPARAGINYLVALYLISOLEUCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHAGE DISPLAY; RADIOASSAY; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; LIGANDS; MICE; MICE, NUDE; NEOPLASMS; PEPTIDES; POLY I-C; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RECEPTOR, EPIDERMAL GROWTH FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84859075506     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1002     Document Type: Article

References (24)

1. Levitzki, A., (2011) Targeting the immune system to cancer using Receptor homing vectors carrying poly inosine/cytosine (PolyIC). Front. Oncol. in press.
2. Shir, A., Ogris, M., Roedl, W., Wagner, E., and, Levitzki, A., (2011) EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice. Clin. Cancer Res. 17, 1033-1043.
3. Shir, A., Ogris, M., Wagner, E., and, Levitzki, A., (2006) EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PLoS Med. 3, e6.
4. Kim, I. Y., Kang, Y. S., Lee, D. S., Park, H. J., Choi, E. K., et al. (2009) Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. J. Control. Release 140, 55-60.
5. Diagaradjane, P., Orenstein-Cardona, J. M., Colon-Casasnovas, N. E., Deorukhkar, A., Shentu, S., et al. (2008) Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin. Cancer Res. 14, 731-741. (Pubitemid 351231154)
6. Wolschek, M. F., Thallinger, C., Kursa, M., Rossler, V., Allen, M., et al. (2002) Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 36, 1106-1114. (Pubitemid 35253426)
7. de Bruin, K., Ruthardt, N., von Gersdorff, K., Bausinger, R., Wagner, E., et al. (2007) Cellular dynamics of EGF receptor-targeted synthetic viruses. Mol. Ther. 15, 1297-1305. (Pubitemid 46965326)
8. Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., et al. (2005) Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J. 19, 1978-1985. (Pubitemid 41759743)
9. Klutz, K., Willhauck, M. J., Dohmen, C., Wunderlich, N., Knoop, K., et al. (2011) Image-guided tumor-selective radioiodine therapy of liver cancer following systemic nonviral delivery of the sodium iodide symporter gene. Hum. Gene Ther. 22, 1563-1574.
10. Schafer, A., Pahnke, A., Schaffert, D., van Weerden, W. M., de Ridder, C. M., et al. Disconnecting the Yin and Yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: A fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation. Hum. Gene Ther. 22, 1463-1473.
11. Schaffert, D., Kiss, M., Rodl, W., Shir, A., Levitzki, A., et al. (2011) Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier. Pharm. Res. 28, 731-741.
12. Goldenberg, A., Masui, H., Divgi, C., Kamrath, H., Pentlow, K., et al. (1989) Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody. J. Natl. Cancer Inst. 81, 1616-1625. (Pubitemid 19264044)
13. Huang, H. S., Nagane, M., Klingbeil, C. K., Lin, H., Nishikawa, R., et al. (1997) The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem. 272, 2927-2935. (Pubitemid 27053343)
14. Dissoki, S., Hagooly, A., Elmachily, S., and, Mishani, E., (2011) Labelling approaches for the GE11 Peptide-an EGFR biomarker. J. Label. Compd. Radiopharm.
15. Song, S., Liu, D., Peng, J., Sun, Y., Li, Z., et al. (2008) Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int. J. Pharm. 363, 155-161.
16. Klutz, K., Schaffert, D., Willhauck, M. J., Grunwald, G. K., Haase, R., et al. Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene. Mol. Ther. 19, 676-685.
17. Liu, T. F., Cohen, K. A., Ramage, J. G., Willingham, M. C., Thorburn, A. M., et al. (2003) A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells. Cancer Res. 63, 1834-1837. (Pubitemid 36460845)
18. Moiseeva, E. P., Heukers, R., and, Manson, M. M., (2007) EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells. Carcinogenesis 28, 435-445. (Pubitemid 46321861)
19. Han, Y., Caday, C. G., Nanda, A., Cavenee, W. K., and, Huang, H. J., (1996) Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer. Res. 56, 3859-3861. (Pubitemid 26284726)
20. Shibuya, K., Komaki, R., Shintani, T., Itasaka, S., Ryan, A., et al. (2007) Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 69, 1534-1543. (Pubitemid 350116420)
21. Peng, K. W., Pham, L., Ye, H., Zufferey, R., Trono, D., et al. (2001) Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8, 1456-1463. (Pubitemid 32994656)
22. Ogris, M., Walker, G., Blessing, T., Kircheis, R., Wolschek, M., et al. (2003) Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Release 91, 173-181. (Pubitemid 37288888)
23. Pereboeva, L., Komarova, S., Roth, J., Ponnazhagan, S., and, Curiel, D. T., (2007) Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus. Gene Ther. 14, 627-637. (Pubitemid 46585622)
24. Schlessinger, J., (2002) Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110, 669-672. (Pubitemid 35283957)